ASX:CSLBiotechs
CSL (ASX:CSL) Reported A Net Loss, Is The Rebound Already Priced In?
CSL (ASX:CSL) is in focus after its latest full year results showed sales and revenue near prior levels, a swing to a net loss, fresh 2027 earnings guidance, and a declared dividend.
See our latest analysis for CSL.
The earnings announcement, new 2027 guidance and dividend decision have triggered a sharp reassessment of CSL, with a 1-day share price return of 17.25% and a 90-day share price return of 60.27%, even though the 1-year total shareholder return is down 28.29% and the 5-year total...

